Summary & Overview
HCPCS G9500: Radiation Exposure Indices for Fluoroscopy
HCPCS Level II code G9500 denotes documentation of radiation exposure indices in the final report for procedures performed with fluoroscopy. Accurate reporting of radiation dose metrics is increasingly important for patient safety, quality measurement, regulatory compliance, and institutional radiation stewardship programs. National attention to radiation dose tracking has expanded the relevance of a standardized code to capture exposure indices alongside clinical procedure documentation.
Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for radiation exposure reporting in fluoroscopy, an explanation of where and when G9500 would typically be documented, and a summary of payer coverage considerations. The publication also outlines benchmarking and reporting expectations, common modifier usage (listed separately), and how G9500 aligns with quality and safety initiatives.
This summary is focused on nationwide implications for billing, reporting, and clinical documentation related to fluoroscopic radiation exposure indices. Data not available in the input will be noted where relevant in detailed sections of the full publication.
Billing Code Overview
HCPCS Level II code G9500 documents radiation exposure indices in the final report for procedures performed using fluoroscopy. This code is used to record quantitative exposure metrics associated with fluoroscopic imaging and is intended for inclusion in the procedure's final report.
-
Service type: Fluoroscopy procedure documentation and reporting
-
Typical site of service: Hospitals, outpatient imaging centers, interventional radiology suites, and other facilities where fluoroscopy-guided procedures are performed
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with symptomatic biliary obstruction undergoes fluoroscopically guided endoscopic retrograde cholangiopancreatography (ERCP) with stent placement. The procedure requires continuous fluoroscopy to cannulate the common bile duct, perform contrast injection, and deploy a stent. The imaging team documents radiation exposure indices (cumulative air kerma, dose-area product [KAP/DRL], and fluoroscopy time) in the final radiology or procedural report to meet regulatory and quality assurance requirements and to inform post-procedure radiation safety review. Typical workflow: pre-procedure consent and indication verification, real-time fluoroscopic imaging by the proceduralist with a technologist recording exposure metrics, documentation of radiation indices in the final procedure report, and post-procedure recovery and discharge or admission based on clinical status.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work or complexity for the fluoroscopic procedure is substantially greater than typical and documented. |
23 | Unusual anesthesia | Use when general anesthesia was medically necessary for the fluoroscopic procedure. |